APA

Rosen T., Seeger T. F., McLean S., Nagel A. A., Ives J. L., Guarino K. J., Bryce D., Furman J., Roth R. W. & Chalabi P. M. (19901206). Synthesis, in vitro binding profile, and central nervous system penetrability of the highly potent 5-HT3 receptor antagonist [3H]-4-(2-methoxyphenyl)-2-[4(5)-methyl-5(4)-imidazolylmethyl]thiazole. : Journal of medicinal chemistry.

Chicago

Rosen T, Seeger T F, McLean S, Nagel A A, Ives J L, Guarino K J, Bryce D, Furman J, Roth R W and Chalabi P M. 19901206. Synthesis, in vitro binding profile, and central nervous system penetrability of the highly potent 5-HT3 receptor antagonist [3H]-4-(2-methoxyphenyl)-2-[4(5)-methyl-5(4)-imidazolylmethyl]thiazole. : Journal of medicinal chemistry.

Harvard

Rosen T., Seeger T. F., McLean S., Nagel A. A., Ives J. L., Guarino K. J., Bryce D., Furman J., Roth R. W. and Chalabi P. M. (19901206). Synthesis, in vitro binding profile, and central nervous system penetrability of the highly potent 5-HT3 receptor antagonist [3H]-4-(2-methoxyphenyl)-2-[4(5)-methyl-5(4)-imidazolylmethyl]thiazole. : Journal of medicinal chemistry.

MLA

Rosen T, Seeger T F, McLean S, Nagel A A, Ives J L, Guarino K J, Bryce D, Furman J, Roth R W and Chalabi P M. Synthesis, in vitro binding profile, and central nervous system penetrability of the highly potent 5-HT3 receptor antagonist [3H]-4-(2-methoxyphenyl)-2-[4(5)-methyl-5(4)-imidazolylmethyl]thiazole. : Journal of medicinal chemistry. 19901206.